Skip to main content
. Author manuscript; available in PMC: 2016 Feb 23.
Published in final edited form as: Clin Cancer Res. 2015 May 27;21(17):3906–3912. doi: 10.1158/1078-0432.CCR-14-2546

Figure 3.

Figure 3

MRI/optical results for patient 6 (lesion size: 48 × 53 × 22 mm, MRI: BIRADs 4a, path: adenosis) and patient 10 (lesion size: 10 × 20 × 19 mm, MRI: BIRADS 4a, path: fibroadenoma). Post-contrast MRI MIP images show abnormality location (left images of A and C) and enhancement pattern. MRI-based region maps (right images of A and C) segmented from T1 MRI were used to guide optical reconstruction. Arrows show locations of optical fibers. Graphs of HbT and TOI contrast correctly characterize the lesions as benign in both cases based on an ROI to normal contrast less than 0.94 and 0.88, respectively, are shown in B and D.